Appreciate the effort that went into this post. However it does not sync up to what I've already posted and re-explained. NADER POURHASSAN, a CYDY officer, in a public forum, said that Dr. Patterson's paper would (paraphrasing) "be published in NEJM next week" (or thereabouts). I, and people smarter than me, made inquiries. NEJM then took the paper out of contention due to NP's violation of the rules by mentioning the NEJM at that juncture. You are right on everything below imo but it has nothing to do WITH MY POST.

Bottom line, NP fumbled this big time for Dr. BP and for shareholders.

I can't keep explaining this over and over. I made calls, I got explanations. I've described it. Believe it or don't. Next.

Quote:

---

I believe the publications are as follows:

NP referenced NEJM publication (Montefiore Correspondence)

https://www.nejm.org/doi/pdf/10.1056/NEJMc201...Tools=true

Dr. BP has never confirmed where his publication would end up. In fact he has flat out said he will not tell us even when asked directly in Q&A's. A prudent move if you have every done academic publishing as you need to get through peer review and the journal approval process first. The only hint we had was from a Dr. Yo comment on one of his first leronlimab videos where he said he spoke directly to Dr. Patterson and he had mentioned to him one of the Journal of Nature's. This was never confirmed by anyone however.

Read More: https://investorshangout.com/post/view?id=582...z6RotWSb2H

---